health care

To address the upcoming Alzheimer’s “epidemic”, let’s approach 2016 with these 4 Pillars of Alzheimer’s Prevention

by

alzheimers-disease-prevention.

As you prob­a­bly know, we are in a health care cri­sis. The num­ber of peo­ple with Alzheimer’s dis­ease con­tin­ues to sky-rock­et as peo­ple age and may reach cri­sis pro­por­tions.  A nation­al goal has been set to pre­vent and cure Alzheimer’s by 2020 or no lat­er than 2025, with a lion’s share of this mon­ey going into drug research, which, while ongo­ing, has thus far has been elusive.

This focus entire­ly on drugs may be chang­ing how­ev­er, as the [Read more…] about To address the upcom­ing Alzheimer’s “epi­dem­ic”, let’s approach 2016 with these 4 Pil­lars of Alzheimer’s Prevention

Time is over for “one size fits all” dementia treatments. Next: How to best integrate non-pharmacologic and pharmacologic approaches

by

Dementia_Alzheimer's

.

Time to ‘just say no’ to behav­ior-calm­ing drugs for Alzheimer patients? Experts say yes (Med­ical Xpress):

“Doc­tors write mil­lions of pre­scrip­tions a year for drugs to calm the behav­ior of peo­ple with Alzheimer’s dis­ease and oth­er types of demen­tia. But non-drug approach­es actu­al­ly work bet­ter, and car­ry far few­er risks, experts con­clude in a new report.

In fact, non-drug approach­es should be the first choice for treat­ing demen­tia patients’ com­mon symp­toms such as [Read more…] about Time is over for “one size fits all” demen­tia treat­ments. Next: How to best inte­grate non-phar­ma­co­log­ic and phar­ma­co­log­ic approaches

Trend: Driving health innovation via patient engagement and market-driven “consumerism”

by

Dr.-Joseph-HahnRetir­ing founder of Cleve­land Clin­ic Inno­va­tions talks tech, Oba­macare and deep brain stim­u­la­tion (Med­C­i­ty News):

“…When I start­ed my career at the Clin­ic, doc­tors were the author­i­ty fig­ure and what­ev­er was said was tak­en as appro­pri­ate. It has been long over­due for patients to get more involved in [Read more…] about Trend: Dri­ving health inno­va­tion via patient engage­ment and mar­ket-dri­ven “con­sumerism”

Under what conditions can mindfulness courses help health care workers manage stress and burnout?

by

stressed_nurseMed­ical pro­fes­sion­als are bur­dened dai­ly with the pain and suf­fer­ing of patients. Many work long hours, and reg­u­lar­ly face stress­ful sit­u­a­tions. This bur­den does not come with­out con­se­quence: 60 per­cent of physi­cians report hav­ing expe­ri­enced burnout at some point in their careers.

Mind­ful­ness cours­es designed to help health care work­ers [Read more…] about Under what con­di­tions can mind­ful­ness cours­es help health care work­ers man­age stress and burnout?

New SharpBrains Summit Partner: The Mars Discovery District

by

mars discoveryWe’re hap­py to count on the sup­port from MaRS Dis­cov­ery Dis­trict, a large scale, mis­sion dri­ven inno­va­tion cen­tre locat­ed in Toron­to and net­worked across Ontario, focused on build­ing Canada’s next gen­er­a­tion of tech­nol­ogy com­pa­nies [Read more…] about New Sharp­Brains Sum­mit Part­ner: The Mars Dis­cov­ery District

The State of Personalized Medicine: The Role of Biomarkers

by

(Edi­tor’s Note: this is Part 1 of the new 3‑part series writ­ten by Dr. Evian Gor­don draw­ing from his par­tic­i­pa­tion at the Per­son­al­ized Med­i­cine World Con­gress on Jan­u­ary, 23, 2012 at Stan­ford University.)

On aver­age, the med­ica­tions pre­scribed for brain-relat­ed con­di­tions ben­e­fit approx­i­mate­ly 50% of patients. But which 50%?

Per­son­al­ized Med­i­cine seeks to move away from the cur­rent “1 size fits all, tri­al and error” approach that has been nec­es­sary because of a lack of evi­dence. Instead, it focus­es on [Read more…] about The State of Per­son­al­ized Med­i­cine: The Role of Biomarkers